When cancer cells compete with immune cells for glucose, the cancer wins. As a result, the immune T cells are not healthy and don't have the weapons to kill the cancer. New research findings, report scientists, have potential as a tool to predict ovarian cancer survival, or a marker to predict effectiveness of immune therapy including checkpoint blockade or immune vaccination.
Cancer cells hijack glucose, alter immune cells
Ready to get ripped?
Introducing the BEST SELLING diet and training program to get you beach-ready for summer.
